BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stoot JH, Coelen RJ, De Jong MC, Dejong CH. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford). 2010;12:509-522. [PMID: 20887318 DOI: 10.1111/j.1477-2574.2010.00222.x] [Cited by in Crossref: 212] [Cited by in F6Publishing: 183] [Article Influence: 21.2] [Reference Citation Analysis]
Number Citing Articles
1 Larson BK, Guindi M. Applying criteria for hepatocellular neoplasm of uncertain malignant potential reclassifies more than half of hepatocellular adenomas. Ann Diagn Pathol 2021;55:151833. [PMID: 34597957 DOI: 10.1016/j.anndiagpath.2021.151833] [Reference Citation Analysis]
2 Cogley JR, Miller FH. MR imaging of benign focal liver lesions. Radiol Clin North Am. 2014;52:657-682. [PMID: 24889166 DOI: 10.1016/j.rcl.2014.02.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
3 McInnes MD, Hibbert RM, Inácio JR, Schieda N. Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid-enhanced MR Imaging--A Systematic Review. Radiology 2015;277:413-23. [PMID: 26020440 DOI: 10.1148/radiol.2015142986] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 9.3] [Reference Citation Analysis]
4 van Aalten SM, Witjes CD, de Man RA, Ijzermans JN, Terkivatan T. Can a decision-making model be justified in the management of hepatocellular adenoma? Liver Int. 2012;32:28-37. [PMID: 22098685 DOI: 10.1111/j.1478-3231.2011.02667.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
5 Margonis GA, Ejaz A, Spolverato G, Rastegar N, Anders R, Kamel IR, Pawlik TM. Benign solid tumors of the liver: management in the modern era. J Gastrointest Surg 2015;19:1157-68. [PMID: 25560181 DOI: 10.1007/s11605-014-2723-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
6 Tse JR, Naini BV, Lu DS, Raman SS. Qualitative and Quantitative Gadoxetic Acid-enhanced MR Imaging Helps Subtype Hepatocellular Adenomas. Radiology 2016;279:118-27. [PMID: 26505921 DOI: 10.1148/radiol.2015142449] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
7 Herman P, Coelho FF, Perini MV, Lupinacci RM, D’Albuquerque LA, Cecconello I. Hepatocellular adenoma: an excellent indication for laparoscopic liver resection. HPB (Oxford). 2012;14:390-395. [PMID: 22568415 DOI: 10.1111/j.1477-2574.2012.00463.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
8 van Rosmalen BV, de Graeff JJ, van der Poel MJ, de Man IE, Besselink M, Abu Hilal M, Busch OR, Verheij J, van Gulik TM; Dutch Benign Liver Tumour Group. Impact of open and minimally invasive resection of symptomatic solid benign liver tumours on symptoms and quality of life: a systematic review. HPB21:1119-1130. [PMID: 30926331 DOI: 10.1016/j.hpb.2019.02.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
9 Balabaud C, Laurent C, Le Bail B, Castain C, Possenti L, Frulio N, Chiche L, Blanc JF, Bioulac-Sage P. Unexpected discovery of small HNF1α-inactivated hepatocellular adenoma in pathological specimens from patients resected for liver tumours. Liver Int 2018;38:1273-9. [PMID: 29265678 DOI: 10.1111/liv.13667] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Matos AP, Velloni F, Ramalho M, AlObaidy M, Rajapaksha A, Semelka RC. Focal liver lesions: Practical magnetic resonance imaging approach. World J Hepatol 2015; 7(16): 1987-2008 [PMID: 26261689 DOI: 10.4254/wjh.v7.i16.1987] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
11 Low G, Dharmana H, Saravana-Bawan S, Girgis S. Case 235: Hepatic Adenomatosis Due to Inflammatory Adenomas. Radiology 2016;281:639-45. [PMID: 27755934 DOI: 10.1148/radiol.2016150420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Dourthe C, Julien C, Di Tommaso S, Dupuy JW, Dugot-Senant N, Brochard A, Le Bail B, Blanc JF, Chiche L, Balabaud C, Bioulac-Sage P, Saltel F, Raymond AA. Proteomic Profiling of Hepatocellular Adenomas Paves the Way to Diagnostic and Prognostic Approaches. Hepatology 2021. [PMID: 33754354 DOI: 10.1002/hep.31826] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Oji K, Urade T, Iwatani Y, Tanaka K, Hirano H, Sanuki T, Tomita M, Yamamoto Y, Zen Y, Kuroda D. Case of resected multiple hepatocellular adenomas in a young man with severe obesity. Surg Case Rep 2019;5:131. [PMID: 31410698 DOI: 10.1186/s40792-019-0689-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 Fukusato T, Soejima Y, Kondo F, Inoue M, Watanabe M, Takahashi Y, Aso T, Uozaki H, Sano K, Sanada Y, Niki T. Preserved or enhanced OATP1B3 expression in hepatocellular adenoma subtypes with nuclear accumulation of β-catenin. Hepatol Res 2015;45:E32-42. [PMID: 25418671 DOI: 10.1111/hepr.12453] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
15 Wong VK, Fung AW, Elsayes KM. Magnetic Resonance Imaging of Hepatic Adenoma Subtypes. Clin Liver Dis (Hoboken) 2021;17:113-8. [PMID: 33868649 DOI: 10.1002/cld.996] [Reference Citation Analysis]
16 Kurosaki K, Uesawa Y. Molecular Initiating Events Associated with Drug-Induced Liver Malignant Tumors: An Integrated Study of the FDA Adverse Event Reporting System and Toxicity Predictions. Biomolecules 2021;11:944. [PMID: 34202146 DOI: 10.3390/biom11070944] [Reference Citation Analysis]
17 Hahn E, Putra J. Hepatocellular adenoma in the paediatric population: Molecular classification and clinical associations. World J Gastroenterol 2020; 26(19): 2294-2304 [PMID: 32476794 DOI: 10.3748/wjg.v26.i19.2294] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Agarwal S, Fuentes-Orrego JM, Arnason T, Misdraji J, Jhaveri KS, Harisinghani M, Hahn PF. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI. AJR Am J Roentgenol. 2014;203:W408-W414. [PMID: 25055198 DOI: 10.2214/ajr.13.12251] [Cited by in Crossref: 49] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
19 Salgia R, Singal AG. Hepatocellular Carcinoma and Other Liver Lesions. Medical Clinics of North America 2014;98:103-18. [DOI: 10.1016/j.mcna.2013.09.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
20 Landi F, De' Angelis N, Scatton O, Vidal X, Ayav A, Muscari F, Dokmak S, Torzilli G, Demartines N, Soubrane O, Cherqui D, Hardwigsen J, Laurent A. Short-term outcomes of laparoscopic vs. open liver resection for hepatocellular adenoma: a multicenter propensity score adjustment analysis by the AFC-HCA-2013 study group. Surg Endosc 2017;31:4136-44. [PMID: 28281121 DOI: 10.1007/s00464-017-5466-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
21 Srirattanapong S, Angthong W, Kim BS, Hayashi PH, Gerber DA, Woosley JT, Peacock J, Ranatunga A, Semelka RC. Liver adenomatosis: serial investigation on MRI. Abdom Imaging 2014;39:269-82. [PMID: 24375021 DOI: 10.1007/s00261-013-0056-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
22 Auer TA, Fehrenbach U, Grieser C, Penzkofer T, Geisel D, Schmelzle M, Müller T, Bläker H, Seehofer D, Denecke T. Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? Eur Radiol 2020;30:3497-506. [PMID: 32086574 DOI: 10.1007/s00330-020-06726-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
23 Johansen L, Haller W, Thyagarajan M, Kelly D, McKiernan P. Hepatic Lesions Associated With McCune Albright Syndrome. J Pediatr Gastroenterol Nutr. 2019;68:e54-e57. [PMID: 30628989 DOI: 10.1097/mpg.0000000000002266] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Chen X, Yamamoto M, Fujii K, Nagahama Y, Ooshio T, Xin B, Okada Y, Furukawa H, Nishikawa Y. Differential reactivation of fetal/neonatal genes in mouse liver tumors induced in cirrhotic and non-cirrhotic conditions. Cancer Sci 2015;106:972-81. [PMID: 26011625 DOI: 10.1111/cas.12700] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
25 Blanc JF, Frulio N, Chiche L, Sempoux C, Annet L, Hubert C, Gouw AS, de Jong KP, Bioulac-Sage P, Balabaud C. Hepatocellular adenoma management: call for shared guidelines and multidisciplinary approach. Clin Res Hepatol Gastroenterol 2015;39:180-7. [PMID: 25434466 DOI: 10.1016/j.clinre.2014.10.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
26 Park HJ, Byun JH, Kang JH, Kang HJ, Yu E, Lee SJ, Kim SY, Won HJ, Shin YM, Kim PN. Value of discrepancy of the central scar-like structure between dynamic CT and gadoxetate disodium-enhanced MRI in differentiation of focal nodular hyperplasia and hepatocellular adenoma. Eur J Radiol 2021;139:109730. [PMID: 33930719 DOI: 10.1016/j.ejrad.2021.109730] [Reference Citation Analysis]
27 Talbot J, Michaud L, Grange J, Rosmorduc O, Balogova S. Use of choline PET for studying hepatocellular carcinoma. Clin Transl Imaging 2014;2:103-13. [DOI: 10.1007/s40336-014-0055-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 Zulfiqar M, Sirlin CB, Yoneda N, Ronot M, Hecht EM, Chernyak V, Matsui O, Bastati N, Ba‐ssalamah A, Chatterjee D, Bashir M, Fowler KJ. Hepatocellular adenomas: Understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach. J Magn Reson Imaging 2020;51:1630-40. [DOI: 10.1002/jmri.26902] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
29 Saldarriaga J, Bisig B, Couchy G, Castain C, Zucman-Rossi J, Balabaud C, Sempoux C, Bioulac-Sage P. Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas. Histopathology 2017;71:989-93. [PMID: 28618047 DOI: 10.1111/his.13283] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
30 Sempoux C, Gouw ASH, Dunet V, Paradis V, Balabaud C, Bioulac-Sage P. Predictive Patterns of Glutamine Synthetase Immunohistochemical Staining in CTNNB1-mutated Hepatocellular Adenomas. Am J Surg Pathol 2021;45:477-87. [PMID: 33560657 DOI: 10.1097/PAS.0000000000001675] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
31 Khaoudy I, Rebibo L, Regimbeau J. Is bariatric surgery a potential new treatment for large inflammatory hepatocellular adenomas in obese patients? Surgery for Obesity and Related Diseases 2018;14:535-8. [DOI: 10.1016/j.soard.2018.01.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
32 Desai A, Sandhu S, Lai JP, Sandhu DS. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World J Hepatol 2019; 11(1): 1-18 [PMID: 30705715 DOI: 10.4254/wjh.v11.i1.1] [Cited by in Crossref: 77] [Cited by in F6Publishing: 59] [Article Influence: 38.5] [Reference Citation Analysis]
33 van Rosmalen BV, Klompenhouwer AJ, de Graeff JJ, Haring MPD, de Meijer VE, Rifai L, Dokmak S, Rawashdeh A, Abu Hilal M, de Jong MC, Dejong CHC, Doukas M, de Man RA, IJzermans JNM, van Delden OM, Verheij J, van Gulik TM; Dutch Benign Liver Tumour Group. Safety and efficacy of transarterial embolization of hepatocellular adenomas. Br J Surg 2019;106:1362-71. [PMID: 31313827 DOI: 10.1002/bjs.11213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
34 Bioulac-Sage P, Sempoux C, Balabaud C. Hepatocellular Adenomas: Morphology and Genomics. Gastroenterol Clin North Am 2017;46:253-72. [PMID: 28506364 DOI: 10.1016/j.gtc.2017.01.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
35 Fernández-Vega I, Santos-Juanes J, Camacho-Urkaray E, Lorente-Gea L, García B, Gutiérrez-Corres FB, Quirós LM, Guerra-Merino I, Aguirre JJ. Miki (Mitotic Kinetics Regulator) Immunoexpression in Normal Liver, Cirrhotic Areas and Hepatocellular Carcinomas: a Preliminary Study with Clinical Relevance. Pathol Oncol Res 2020;26:167-73. [PMID: 29435733 DOI: 10.1007/s12253-018-0387-7] [Reference Citation Analysis]
36 Cheng L, Liu Y, Wang W, Merritt JL, Yeh M. Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency. Case Reports Hepatol 2019;2019:2313791. [PMID: 31662921 DOI: 10.1155/2019/2313791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Thevathasan T, Colbatzky T, Schmelzle M, Pratschke J, Krenzien F. Risk factors for malignant transformation of hepatocellular adenoma to hepatocellular carcinoma: protocol for systematic review and meta-analysis. BMJ Open 2021;11:e045733. [PMID: 34376442 DOI: 10.1136/bmjopen-2020-045733] [Reference Citation Analysis]
38 Tsilimigras DI, Rahnemai-azar AA, Ntanasis-stathopoulos I, Gavriatopoulou M, Moris D, Spartalis E, Cloyd JM, Weber SM, Pawlik TM. Current Approaches in the Management of Hepatic Adenomas. J Gastrointest Surg 2019;23:199-209. [DOI: 10.1007/s11605-018-3917-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
39 Ostojic A, Mrzljak A, Mikulic D. Liver transplantation for benign liver tumors. World J Hepatol 2021; 13(9): 1098-1106 [PMID: 34630877 DOI: 10.4254/wjh.v13.i9.1098] [Reference Citation Analysis]
40 Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol 2012;56:1384-91. [PMID: 22326465 DOI: 10.1016/j.jhep.2011.10.027] [Cited by in Crossref: 536] [Cited by in F6Publishing: 505] [Article Influence: 59.6] [Reference Citation Analysis]
41 Goltz D, Fischer HP. Current Proceedings in the Molecular Dissection of Hepatocellular Adenomas: Review and Hands-on Guide for Diagnosis. Int J Mol Sci 2015;16:20994-1007. [PMID: 26404250 DOI: 10.3390/ijms160920994] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
42 Bossen L, Grønbaek H, Lykke Eriksen P, Jepsen P. Men with biopsy-confirmed hepatocellular adenoma have a high risk of progression to hepatocellular carcinoma: A nationwide population-based study. Liver Int 2017;37:1042-6. [DOI: 10.1111/liv.13423] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
43 Grieser C, Denecke T, Schmidt SC. An unusual cause of recurrent acute abdominal pain. Gastroenterology 2012;142:e5-6. [PMID: 22370212 DOI: 10.1053/j.gastro.2011.09.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
44 Cannella R, Brancatelli G, Rangaswamy B, Minervini MI, Borhani AA, Furlan A. Enhancement pattern of hepatocellular adenoma (HCA) on MR imaging performed with Gd-EOB-DTPA versus other Gd-based contrast agents (GBCAs): An intraindividual comparison. Eur J Radiol 2019;119:108633. [PMID: 31437747 DOI: 10.1016/j.ejrad.2019.08.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
45 An SL, Wang LM, Rong WQ, Wu F, Sun W, Yu WB, Feng L, Liu FQ, Tian F, Wu JX. Hepatocellular adenoma with malignant transformation in male patients with non-cirrhotic livers. Chin J Cancer 2015;34:217-24. [PMID: 26058379 DOI: 10.1186/s40880-015-0014-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
46 van Rosmalen BV, Coelen RJS, Bieze M, van Delden OM, Verheij J, Dejong CHC, van Gulik TM. Systematic review of transarterial embolization for hepatocellular adenomas. British Journal of Surgery 2017;104:823-35. [DOI: 10.1002/bjs.10547] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
47 Paradis V. Hepatocellular Adenomas. Surgical Pathology Clinics 2013;6:311-31. [DOI: 10.1016/j.path.2013.03.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Engelhardt EM, Trout AT, Sheridan RM, Veldtman GR, Dillman JR. Focal liver lesions following Fontan palliation of single ventricle physiology: A radiology‐pathology case series. Congenital Heart Disease 2019;14:380-8. [DOI: 10.1111/chd.12730] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
49 Henriet E, Abou Hammoud A, Dupuy J, Dartigues B, Ezzoukry Z, Dugot-senant N, Leste-lasserre T, Pallares-lupon N, Nikolski M, Le Bail B, Blanc J, Balabaud C, Bioulac-sage P, Raymond A, Saltel F. Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk: Henriet, Abou Hammoud, et al. Hepatology 2017;66:2016-28. [DOI: 10.1002/hep.29336] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 12.0] [Reference Citation Analysis]
50 Mouhoub M, Miry A, Haloui A, Karich N, Kamaoui I, Soufi M, Bennani A. Malignant transformation of hepatocellular adenoma: report of a case. Pan Afr Med J 2020;35:92. [PMID: 32636990 DOI: 10.11604/pamj.2020.35.92.17416] [Reference Citation Analysis]
51 Schmelzle M, Krenzien F, Schöning W, Pratschke J. [Treatment of hepatocellular carcinoma in the cirrhotic and non-cirrhotic liver]. Chirurg 2018;89:851-7. [PMID: 30109374 DOI: 10.1007/s00104-018-0690-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Bieze M, van den Esschert JW, Nio CY, Verheij J, Reitsma JB, Terpstra V, van Gulik TM, Phoa SS. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR Am J Roentgenol. 2012;199:26-34. [PMID: 22733890 DOI: 10.2214/ajr.11.7750] [Cited by in Crossref: 78] [Cited by in F6Publishing: 37] [Article Influence: 8.7] [Reference Citation Analysis]
53 O’neill EK, Cogley JR, Miller FH. The Ins and Outs of Liver Imaging. Clinics in Liver Disease 2015;19:99-121. [DOI: 10.1016/j.cld.2014.09.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
54 Mironov O, Jaberi A, Beecroft R, Kachura JR. Retrospective Single-Arm Cohort Study of Patients with Hepatocellular Adenomas Treated with Percutaneous Thermal Ablation. Cardiovasc Intervent Radiol 2018;41:935-41. [DOI: 10.1007/s00270-018-1893-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
55 Dong Y, Zhu Z, Wang WP, Mao F, Ji ZB. Ultrasound features of hepatocellular adenoma and the additional value of contrast-enhanced ultrasound. Hepatobiliary Pancreat Dis Int. 2016;15:48-54. [PMID: 26818543 DOI: 10.1016/s1499-3872(15)60039-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
56 Sempoux C, Chang C, Gouw A, Chiche L, Zucman-Rossi J, Balabaud C, Bioulac-Sage P. Benign hepatocellular nodules: what have we learned using the patho-molecular classification. Clin Res Hepatol Gastroenterol. 2013;37:322-327. [PMID: 23876350 DOI: 10.1016/j.clinre.2013.04.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
57 Sala M, Gonzales D, Leste-Lasserre T, Dugot-Senant N, Paradis V, Di Tommaso S, Dupuy JW, Pitard V, Dourthe C, Sciarra A, Sempoux C, Ferrell LD, Clouston AD, Miller G, Yeh MM, Thung S, Gouw ASH, Quaglia A, Han J, Huan J, Fan C, Crawford J, Nakanuma Y, Harada K, le Bail B, Castain C, Frulio N, Trillaud H, Possenti L, Blanc JF, Chiche L, Laurent C, Balabaud C, Bioulac-Sage P, Raymond AA, Saltel F. ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice. Hepatol Commun 2020;4:809-24. [PMID: 32490318 DOI: 10.1002/hep4.1514] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
58 Kudo M. Malignant transformation of hepatocellular adenoma: how frequently does it happen? Liver Cancer 2015;4:1-5. [PMID: 26020024 DOI: 10.1159/000367726] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
59 Colombo M. Diagnosis of liver nodules within and outside screening programs. Annals of Hepatology 2015;14:304-9. [DOI: 10.1016/s1665-2681(19)31268-2] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
60 van Vledder MG, van Aalten SM, Terkivatan T, de Man RA, Leertouwer T, Ijzermans JN. Safety and efficacy of radiofrequency ablation for hepatocellular adenoma. J Vasc Interv Radiol 2011;22:787-93. [PMID: 21616431 DOI: 10.1016/j.jvir.2011.02.024] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
61 Kim H, Park YN. Role of biopsy sampling for diagnosis of early and progressed hepatocellular carcinoma. Best Practice & Research Clinical Gastroenterology 2014;28:813-29. [DOI: 10.1016/j.bpg.2014.08.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
62 Zhao C, Pei S-, Cucchetti A, Tong T-, Ma Y-, Zhong J-, Li L-. Retracted: Systematic review: benefits and harms of transarterial embolisation for treating hepatocellular adenoma. Aliment Pharmacol Ther 2017;46:83-83. [DOI: 10.1111/apt.14044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
63 Lee SY, Kingham TP, LaGratta MD, Jessurun J, Cherqui D, Jarnagin WR, Kluger MD. PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions. HPB (Oxford) 2016;18:41-8. [PMID: 26776850 DOI: 10.1016/j.hpb.2015.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
64 Blanc JF, Frulio N, Chiche L, Bioulac-Sage P, Balabaud C. Hepatocellular adenoma management: advances but still a long way to go. Hepat Oncol. 2015;2:171-180. [PMID: 30190996 DOI: 10.2217/hep.14.41] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
65 de'Angelis N, Memeo R, Calderaro J, Felli E, Salloum C, Compagnon P, Luciani A, Laurent A, Cherqui D, Azoulay D. Open and laparoscopic resection of hepatocellular adenoma: trends over 23 years at a specialist hepatobiliary unit. HPB (Oxford). 2014;16:783-788. [PMID: 24852081 DOI: 10.1111/hpb.12257] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
66 Roncalli M, Sciarra A, Tommaso LD. Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma. Clin Mol Hepatol 2016;22:199-211. [PMID: 27189732 DOI: 10.3350/cmh.2016.0101] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
67 Méndez-Sánchez N, Ridruejo E, Alves de Mattos A, Chávez-Tapia NC, Zapata R, Paraná R, Mastai R, Strauss E, Guevara-Casallas LG, Daruich J, Gadano A, Parise ER, Uribe M, Aguilar-Olivos NE, Dagher L, Ferraz-Neto BH, Valdés-Sánchez M, Sánchez-Avila JF. Latin American Association for the Study of the Liver (LAASL) clinical practice guidelines: management of hepatocellular carcinoma. Ann Hepatol 2014;13 Suppl 1:S4-40. [PMID: 24998696 [PMID: 24998696 DOI: 10.1016/s1665-2681(19)30919-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 2.8] [Reference Citation Analysis]
68 Haring MPD, Spijkerboer CS, Cuperus FJC, Duiker EW, de Jong KP, de Haas RJ, de Meijer VE. Behavior and complications of hepatocellular adenoma during pregnancy and puerperium: a retrospective study and systematic review. HPB (Oxford) 2021;23:1152-63. [PMID: 33985906 DOI: 10.1016/j.hpb.2021.04.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Haring MPD, Gouw ASH, de Haas RJ, Cuperus FJC, de Jong KP, de Meijer VE. The effect of oral contraceptive pill cessation on hepatocellular adenoma diameter: A retrospective cohort study. Liver Int. 2019;39:905-913. [PMID: 30773766 DOI: 10.1111/liv.14074] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
70 Grieser C, Steffen IG, Kramme IB, Bläker H, Kilic E, Perez Fernandez CM, Seehofer D, Schott E, Hamm B, Denecke T. Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience. Eur Radiol 2014;24:1339-48. [PMID: 24658870 DOI: 10.1007/s00330-014-3144-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
71 Ronot M, Benzimra J, Bouda D, Vilgrain V. Letter to the Editor re: Should fat in the radiofrequency ablation zone of hepatocellular adenomas raise suspicion for residual tumour? Eur Radiol 2017;27:2235-6. [PMID: 27757520 DOI: 10.1007/s00330-016-4639-1] [Reference Citation Analysis]
72 Dokmak S, Cauchy F, Belghiti J. Resection, transplantation and local regional therapies for liver adenomas. Expert Rev Gastroenterol Hepatol 2014;8:803-10. [PMID: 24957321 DOI: 10.1586/17474124.2014.917957] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
73 Cedillo MA, Wong J, Song JW, Liao J. A rare case of hepatocellular carcinoma arising from gadoxetate-retaining hepatic adenoma. Radiol Case Rep 2020;15:141-3. [PMID: 31827660 DOI: 10.1016/j.radcr.2019.10.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Zamora-Valdes D, Taner T, Nagorney DM. Surgical Treatment of Hepatocellular Carcinoma. Cancer Control 2017;24:1073274817729258. [PMID: 28975836 DOI: 10.1177/1073274817729258] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
75 Liau SS, Qureshi MS, Praseedom R, Huguet E. Molecular pathogenesis of hepatic adenomas and its implications for surgical management. J Gastrointest Surg. 2013;17:1869-1882. [PMID: 23835731 DOI: 10.1007/s11605-013-2274-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
76 Koehne de Gonzalez AK, Salomao MA, Lagana SM. Current concepts in the immunohistochemical evaluation of liver tumors. World J Hepatol 2015; 7(10): 1403-1411 [PMID: 26052385 DOI: 10.4254/wjh.v7.i10.1403] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
77 Cox VL, Bhosale P, Varadhachary GR, Wagner-bartak N, Glitza IC, Gold KA, Atkins JT, Soliman PT, Hong DS, Qayyum A. Cancer Genomics and Important Oncologic Mutations: A Contemporary Guide for Body Imagers. Radiology 2017;283:314-40. [DOI: 10.1148/radiol.2017152224] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
78 Woodward C, Smith J, Acreman D, Kumar N. Hepatocellular carcinoma in body builders; an emerging rare but serious complication of androgenic anabolic steroid use. Ann Hepatobiliary Pancreat Surg 2019;23:174-7. [PMID: 31225420 DOI: 10.14701/ahbps.2019.23.2.174] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
79 Ponnatapura J, Kielar A, Burke LM, Lockhart ME, Abualruz A, Tappouni R, Lalwani N. Hepatic complications of oral contraceptive pills and estrogen on MRI: Controversies and update - Adenoma and beyond. Magnetic Resonance Imaging 2019;60:110-21. [DOI: 10.1016/j.mri.2019.04.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
80 Suh CH, Kim KW, Park SH, Shin S, Ahn J, Pyo J, Shinagare AB, Krajewski KM, Ramaiya NH. A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma. Eur Radiol. 2018;28:214-225. [PMID: 28726119 DOI: 10.1007/s00330-017-4967-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
81 Kakar S, Grenert JP, Paradis V, Pote N, Jakate S, Ferrell LD. Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor. Mod Pathol. 2014;27:1499-1509. [PMID: 24743216 DOI: 10.1038/modpathol.2014.50] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
82 Mergental H, Adam R, Ericzon B, Kalicinski P, Mühlbacher F, Höckerstedt K, Klempnauer JL, Friman S, Broelsch CE, Mantion G, Fernandez-sellez C, van Hoek B, Fangmann J, Pirenne J, Muiesan P, Königsrainer A, Mirza DF, Lerut J, Detry O, Le Treut Y, Mazzaferro V, Löhe F, Berenguer M, Clavien P, Rogiers X, Belghiti J, Kóbori L, Burra P, Wolf P, Schareck W, Pisarski P, Foss A, Filipponi F, Krawczyk M, Wolff M, Langrehr JM, Rolles K, Jamieson N, Hop WC, Porte RJ. Liver transplantation for unresectable hepatocellular carcinoma in normal livers. Journal of Hepatology 2012;57:297-305. [DOI: 10.1016/j.jhep.2012.03.022] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
83 Belghiti J, Cauchy F, Paradis V, Vilgrain V. Diagnosis and management of solid benign liver lesions. Nat Rev Gastroenterol Hepatol. 2014;11:737-749. [PMID: 25178878 DOI: 10.1038/nrgastro.2014.151] [Cited by in Crossref: 57] [Cited by in F6Publishing: 42] [Article Influence: 8.1] [Reference Citation Analysis]
84 Shen XY, Hu XG, Kim YB, Kim MN, Hong SY, Kim BW, Wang HJ. Molecular classification of hepatocellular adenoma: A single-center experience. Ann Hepatobiliary Pancreat Surg 2019;23:109-14. [PMID: 31225410 DOI: 10.14701/ahbps.2019.23.2.109] [Reference Citation Analysis]
85 Karagozian R, Derdák Z, Baffy G. Obesity-associated mechanisms of hepatocarcinogenesis. Metabolism 2014;63:607-17. [DOI: 10.1016/j.metabol.2014.01.011] [Cited by in Crossref: 102] [Cited by in F6Publishing: 100] [Article Influence: 14.6] [Reference Citation Analysis]
86 Lee SY, Kingham TP, LaGratta MD, Jessurun J, Cherqui D, Jarnagin WR, Kluger MD. PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions. HPB (Oxford) 2015. [PMID: 26472264 DOI: 10.1111/hpb.12489] [Reference Citation Analysis]
87 Silva TS, Sung M, Nelson DW, DiFronzo AL, O'Connor VV. A Multicenter, 10-Year Experience With Hepatocellular Adenoma: Risk Factors and Disease Course. Am Surg 2021;:31348211011084. [PMID: 33861649 DOI: 10.1177/00031348211011084] [Reference Citation Analysis]
88 Glinka J, Clariá RS, Fratanoni E, Spina J, Mullen E, Ardiles V, Mazza O, Pekolj J, de Santibañes M, de Santibañes E. Malignant transformation of hepatocellular adenoma in a young female patient after ovulation induction fertility treatment: A case report. World J Gastrointestinal Surgery 2019; 11(4): 229-236 [PMID: 31123560 DOI: 10.4240/wjgs.v11.i4.229] [Reference Citation Analysis]
89 Bioulac-sage P, Cubel G, Taouji S, Scoazec J, Leteurtre E, Paradis V, Sturm N, Van Nhieu JT, Wendum D, Bancel B, Ramos J, Paraf F, Saint Paul MC, Michalak S, Fabre M, Guettier C, Le Bail B, Zucman-rossi J, Balabaud C. Immunohistochemical Markers on Needle Biopsies Are Helpful for the Diagnosis of Focal Nodular Hyperplasia and Hepatocellular Adenoma Subtypes. American Journal of Surgical Pathology 2012;36:1691-9. [DOI: 10.1097/pas.0b013e3182653ece] [Cited by in Crossref: 89] [Cited by in F6Publishing: 25] [Article Influence: 9.9] [Reference Citation Analysis]
90 Resaz R, Rosa F, Grillo F, Basso L, Segalerba D, Puglisi A, Bosco MC, Mastracci L, Neumaier CE, Varesio L, Eva A. Characterization of high- and low-risk hepatocellular adenomas by magnetic resonance imaging in an animal model of glycogen storage disease type 1A. Dis Model Mech. 2019;12. [PMID: 30898969 DOI: 10.1242/dmm.038026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Chopinet S, Cauchy F, Hobeika C, Beaufrère A, Poté N, Farges O, Dokmak S, Bouattour M, Ronot M, Vilgrain V, Paradis V, Soubrane O. Long-term outcomes following resection of hepatocellular adenomas with small foci of malignant transformation or malignant adenomas. JHEP Rep 2021;3:100326. [PMID: 34368664 DOI: 10.1016/j.jhepr.2021.100326] [Reference Citation Analysis]
92 Bioulac-Sage P, Sempoux C, Possenti L, Frulio N, Laumonier H, Laurent C, Chiche L, Frédéric Blanc J, Saric J, Trillaud H, Le Bail B, Balabaud C. Pathological Diagnosis of Hepatocellular Cellular Adenoma according to the Clinical Context. Int J Hepatol 2013;2013:253261. [PMID: 23691330 DOI: 10.1155/2013/253261] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
93 Klompenhouwer AJ, Bröker MEE, Thomeer MGJ, Gaspersz MP, de Man RA, Ijzermans JNM. Retrospective study on timing of resection of hepatocellular adenoma. British Journal of Surgery 2017;104:1695-703. [DOI: 10.1002/bjs.10594] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
94 van Aalten SM, Bröker ME, Busschbach JJ, de Koning HJ, de Man RA, Steegers EA, Steyerberg EW, Terkivatan T, Ijzermans JN. Pregnancy and liver adenoma management: PALM-study. BMC Gastroenterol 2012;12:82. [PMID: 22748109 DOI: 10.1186/1471-230X-12-82] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
95 Thomeer MG, Broker M, Verheij J, Doukas M, Terkivatan T, Bijdevaate D, De Man RA, Moelker A, IJzermans JN. Hepatocellular adenoma: when and how to treat? Update of current evidence. Therap Adv Gastroenterol. 2016;9:898-912. [PMID: 27803743 DOI: 10.1177/1756283x16663882] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 5.8] [Reference Citation Analysis]
96 van Rosmalen BV, Furumaya A, Klompenhouwer AJ, Tushuizen ME, Braat AE, Reinten RJ, Ligthart MAP, Haring MPD, de Meijer VE, van Voorthuizen T, Takkenberg RB, Dejong CHC, de Man RA, IJzermans JNM, Doukas M, van Gulik TM, Verheij J; Dutch Benign Liver Tumor Group and the PALGA group. Hepatocellular adenoma in men: A nationwide assessment of pathology and correlation with clinical course. Liver Int 2021. [PMID: 34155783 DOI: 10.1111/liv.14989] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
97 Okuno M, Newhook TE, Joechle K, Kawaguchi Y, De Bellis M, Tzeng CD, Chun YS, Aloia TA, Shindoh J, Kaseb AO, Vauthey JN. Characteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma? HPB (Oxford) 2020;22:545-52. [PMID: 31533893 DOI: 10.1016/j.hpb.2019.08.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
98 Mathew RP, Manolea F, Girgis S, Patel V, Low G. Malignant transformation of hepatic adenoma complicated by rupture and hemorrhage: An extremely rare clinical entity. Intractable Rare Dis Res 2019;8:266-70. [PMID: 31890454 DOI: 10.5582/irdr.2019.01089] [Reference Citation Analysis]
99 Visentin M, van Rosmalen BV, Hiller C, Bieze M, Hofstetter L, Verheij J, Kullak-ublick GA, Koepsell H, Phoa SS, Tamai I, Bennink RJ, van Gulik TM, Stieger B. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions. Drug Metab Dispos 2017;45:166-73. [DOI: 10.1124/dmd.116.072371] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
100 Nault JC, Bioulac-Sage P, Zucman-Rossi J. Hepatocellular benign tumors-from molecular classification to personalized clinical care. Gastroenterology. 2013;144:888-902. [PMID: 23485860 DOI: 10.1053/j.gastro.2013.02.032] [Cited by in Crossref: 199] [Cited by in F6Publishing: 145] [Article Influence: 24.9] [Reference Citation Analysis]
101 曹亚昭, 程书权. 乙型肝炎合并肝脏巨大腺瘤1例. 世界华人消化杂志 2017; 25(14): 1316-1320 [DOI: 10.11569/wcjd.v25.i14.1316] [Reference Citation Analysis]
102 Khalaf AM, Fuentes D, Morshid AI, Burke MR, Kaseb AO, Hassan M, Hazle JD, Elsayes KM. Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance. J Hepatocell Carcinoma 2018;5:61-73. [PMID: 29984212 DOI: 10.2147/JHC.S156701] [Cited by in Crossref: 68] [Cited by in F6Publishing: 44] [Article Influence: 22.7] [Reference Citation Analysis]
103 van Rosmalen BV, Bieze M, Besselink MG, Tanis P, Verheij J, Phoa SS, Busch O, van Gulik TM. Long-term outcomes of resection in patients with symptomatic benign liver tumours. HPB (Oxford) 2016;18:908-14. [PMID: 27553837 DOI: 10.1016/j.hpb.2016.07.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
104 Khanna M, Ramanathan S, Fasih N, Schieda N, Virmani V, McInnes MD. Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenoma. Insights Imaging. 2015;6:347-362. [PMID: 25790815 DOI: 10.1007/s13244-015-0399-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
105 Krause K, Tanabe KK. A Shifting Paradigm in Diagnosis and Management of Hepatic Adenoma. Ann Surg Oncol 2020;27:3330-8. [PMID: 32542565 DOI: 10.1245/s10434-020-08580-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
106 Ng K, Mogul DB. Pediatric Liver Tumors. Clin Liver Dis 2018;22:753-72. [PMID: 30266161 DOI: 10.1016/j.cld.2018.06.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
107 Kang HJ, Jeong HJ, Kim SW, Yu E, Lee YJ, Kim SY, Kim J. Hepatocellular Carcinoma Arising in a Huge Hepatocellular Adenoma with Bone Marrow Metaplasia. J Pathol Transl Med 2018;52:226-31. [PMID: 29281780 DOI: 10.4132/jptm.2017.11.12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
108 Zheng LP, Hu CD, Wang J, Chen XJ, Shen YY. Radiological aspects of giant hepatocellular adenoma of the left liver: A case report. World J Clin Cases 2019; 7(23): 4111-4118 [PMID: 31832416 DOI: 10.12998/wjcc.v7.i23.4111] [Reference Citation Analysis]
109 Larson BK, Guindi M. A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice. Am J Clin Pathol 2017;147:557-70. [PMID: 28472207 DOI: 10.1093/ajcp/aqx010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
110 Bise S, Frulio N, Hocquelet A, Alberti N, Blanc JF, Laurent C, Laumonier H, Balabaud C, Bioulac-Sage P, Trillaud H. New MRI features improve subtype classification of hepatocellular adenoma. Eur Radiol 2019;29:2436-47. [PMID: 30523457 DOI: 10.1007/s00330-018-5784-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
111 Burgis JC, Pratt CA, Higgins JP, Kerner JA. Multiple hepatic adenomas in a child with microvillus inclusion disease. Dig Dis Sci. 2013;58:2784-2788. [PMID: 23525737 DOI: 10.1007/s10620-013-2646-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
112 Liu TC, Vachharajani N, Chapman WC, Brunt EM. Noncirrhotic hepatocellular carcinoma: derivation from hepatocellular adenoma? Clinicopathologic analysis. Mod Pathol 2014;27:420-32. [PMID: 24051694 DOI: 10.1038/modpathol.2013.148] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
113 Sanada Y, Mizuta K, Niki T, Tashiro M, Hirata Y, Okada N, Yamada N, Ihara Y, Urahashi T, Soejima Y, Fukusato T, Kondo F. Hepatocellular nodules resulting from congenital extrahepatic portosystemic shunts can differentiate into potentially malignant hepatocellular adenomas. J Hepatobiliary Pancreat Sci 2015;22:746-56. [DOI: 10.1002/jhbp.277] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
114 Poddar N, Ramlal R, Ravulapati S, Devlin SM, Gadani S, Vidal CI, Cao D, Befeler AS, Lai J. Extrahepatic metastasis of hepatocellular carcinoma arising from a hepatic adenoma without concurrent intrahepatic recurrence. Curr Oncol 2017;24:e333-6. [PMID: 28874904 DOI: 10.3747/co.24.3494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
115 Kassahun WT. Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developments. World J Surg Oncol 2016;14:151. [PMID: 27215576 DOI: 10.1186/s12957-016-0903-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
116 Strauss E, Ferreira Ade S, França AV, Lyra AC, Barros FM, Silva I, Garcia JH, Parise ER. Diagnosis and treatment of benign liver nodules: Brazilian Society of Hepatology (SBH) recommendations. Arq Gastroenterol 2015;52 Suppl 1:47-54. [PMID: 26959805 DOI: 10.1590/S0004-28032015000500003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
117 Dharmana H, Saravana-bawan S, Girgis S, Low G. Hepatocellular adenoma: imaging review of the various molecular subtypes. Clinical Radiology 2017;72:276-85. [DOI: 10.1016/j.crad.2016.12.020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
118 Oliveira S, Samba AK, Towbin AJ, Gupta A, Geller JI, Nathan JD, Kohli R. Incidental inflammatory adenoma with β-catenin activation in the setting of paediatric NASH. Pediatr Obes 2018;13:70-3. [PMID: 27780309 DOI: 10.1111/ijpo.12189] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
119 van Aalten SM, Thomeer MG, Terkivatan T, Dwarkasing RS, Verheij J, de Man RA, Ijzermans JN. Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology. 2011;261:172-181. [PMID: 21875850 DOI: 10.1148/radiol.11110023] [Cited by in Crossref: 157] [Cited by in F6Publishing: 130] [Article Influence: 15.7] [Reference Citation Analysis]
120 Gaspersz MP, Klompenhouwer AJ, Broker MEE, Thomeer MGJ, van Aalten SM, Steegers E, Terkivatan T, de Koning H, de Man RA, Ijzermans JNM. Growth of hepatocellular adenoma during pregnancy: A prospective study. J Hepatol 2020;72:119-24. [PMID: 31550458 DOI: 10.1016/j.jhep.2019.09.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
121 Young JR, Graham RP, Venkatesh SK, Kendi AT. 18F-FDG PET/CT of hepatocellular adenoma subtypes and review of literature. Abdom Radiol (NY) 2021;46:2604-9. [PMID: 33555390 DOI: 10.1007/s00261-021-02968-2] [Reference Citation Analysis]
122 Younes R, Bugianesi E. Should we undertake surveillance for HCC in patients with NAFLD? Journal of Hepatology 2018;68:326-34. [DOI: 10.1016/j.jhep.2017.10.006] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 25.3] [Reference Citation Analysis]
123 Cannella R, Borhani AA, Minervini MI, Tsung A, Furlan A. Evaluation of texture analysis for the differential diagnosis of focal nodular hyperplasia from hepatocellular adenoma on contrast-enhanced CT images. Abdom Radiol44:1323-1330. [PMID: 30267107 DOI: 10.1007/s00261-018-1788-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
124 Tran Cao HS, Marcal LP, Mason MC, Yedururi S, Joechle K, Wei SH, Vauthey J. Benign hepatic incidentalomas. Current Problems in Surgery 2019;56:100642. [DOI: 10.1067/j.cpsurg.2019.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
125 Willson JS, Godwin TD, Wiggins GA, Guilford PJ, McCall JL. Primary hepatocellular neoplasms in a MODY3 family with a novel HNF1A germline mutation. J Hepatol. 2013;59:904-907. [PMID: 23707370 DOI: 10.1016/j.jhep.2013.05.024] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
126 Anwar SL, Albat C, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, Kreipe H, Lehmann U. Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker. Int J Cancer. 2013;133:660-670. [PMID: 23364900 DOI: 10.1002/ijc.28068] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 6.3] [Reference Citation Analysis]
127 Balabaud C, Al-Rabih WR, Chen PJ, Evason K, Ferrell L, Hernandez-Prera JC, Huang SF, Longerich T, Park YN, Quaglia A. Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification. Int J Hepatol. 2013;2013:268625. [PMID: 23691331 DOI: 10.1155/2013/268625] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
128 Klompenhouwer AJ, Alblas M, van Rosmalen BV, Haring MPD, Venema E, Doukas M, Thomeer MGJ, Takkenberg RB, Verheij J, de Meijer VE, van Gulik TM, Lingsma HF, de Man RA, Ijzermans JNM. Development and Validation of a Model to Predict Regression of Large Size Hepatocellular Adenoma. Am J Gastroenterol 2019;114:1292-8. [DOI: 10.14309/ajg.0000000000000182] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
129 Yacoub H, Kchir H, Cherif D, Hassine H, Haouet S, Ayari A, Mizouni H, Mannai S, Khalfallah MT, Maamouri N. Hepatocellular carcinoma arising from hepatic adenoma in a young woman. Clin Case Rep 2020;8:1659-62. [PMID: 32983471 DOI: 10.1002/ccr3.2975] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 van Aalten SM, de Man RA, IJzermans JN, Terkivatan T. Systematic review of haemorrhage and rupture of hepatocellular adenomas. Br J Surg. 2012;99:911-916. [PMID: 22619025 DOI: 10.1002/bjs.8762] [Cited by in Crossref: 107] [Cited by in F6Publishing: 94] [Article Influence: 11.9] [Reference Citation Analysis]
131 Guo Y, Li W, Cai W, Zhang Y, Fang Y, Hong G. Diagnostic Value of Gadoxetic Acid-Enhanced MR Imaging to Distinguish HCA and Its Subtype from FNH: A Systematic Review. Int J Med Sci 2017;14:668-74. [PMID: 28824299 DOI: 10.7150/ijms.17865] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
132 Ronot M, Vilgrain V. Reply to: "Indication of Percutaneous Microwave Ablation for the Treatment of Hepatic Adenomas: Squaring the Circle". J Vasc Interv Radiol 2016;27:932-3. [PMID: 27287977 DOI: 10.1016/j.jvir.2016.02.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
133 Thian YL, Riddell AM, Koh DM. Liver-specific agents for contrast-enhanced MRI: role in oncological imaging. Cancer Imaging. 2013;13:567-579. [PMID: 24434892 DOI: 10.1102/1470-7330.2013.0050] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
134 Herman P, Fonseca GM, Kruger JAP, Jeismann VB, Coelho FF. Guidelines for the Treatment of Hepatocellular Adenoma in the Era of Molecular Biology: An Experience-Based Surgeons’ Perspective. J Gastrointest Surg 2021;25:1494-502. [DOI: 10.1007/s11605-020-04724-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Torbenson M. Hepatic Adenomas. Surgical Pathology Clinics 2018;11:351-66. [DOI: 10.1016/j.path.2018.02.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
136 Pillon M, Carucci NS, Mainardi C, Carraro E, Zuliani M, Chemello L, Calore E, Tumino M, Varotto S, Toffolutti T, Destro R, Gazzola MV, Alaggio R, Basso G, Messina C. Focal nodular hyperplasia of the liver: an emerging complication of hematopoietic SCT in children. Bone Marrow Transplant 2015;50:414-9. [PMID: 25581411 DOI: 10.1038/bmt.2014.276] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
137 van Aalten SM, Terkivatan T, van der Linden E, Verheij J, de Man RA, Ijzermans JN. Management of liver adenomatosis by radiofrequency ablation. Dig Surg 2011;28:173-7. [PMID: 21540605 DOI: 10.1159/000323746] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
138 Souza LN, de Martino RB, Thompson R, Strautnieks S, Heaton ND, Quaglia A. Pigmented well-differentiated hepatocellular neoplasm with β-catenin mutation. Hepatobiliary & Pancreatic Diseases International 2015;14:660-4. [DOI: 10.1016/s1499-3872(15)60381-2] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
139 Pilati C, Zucman-rossi J. Mutations leading to constitutive active gp130/JAK1/STAT3 pathway. Cytokine & Growth Factor Reviews 2015;26:499-506. [DOI: 10.1016/j.cytogfr.2015.07.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
140 Garcovich M, Faccia M, Meloni F, Bertolini E, de Sio I, Calabria G, Francica G, Vidili G, Riccardi L, Zocco MA, Ainora ME, Ponziani FR, De Gaetano AM, Gasbarrini A, Rapaccini GL, Pompili M. Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience. J Ultrasound 2019;22:157-65. [PMID: 30306412 DOI: 10.1007/s40477-018-0322-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
141 Bieze M, Busch OR, Tanis PJ, Verheij J, Phoa SS, Gouma DJ, van Gulik TM. Outcomes of liver resection in hepatocellular adenoma and focal nodular hyperplasia. HPB (Oxford) 2014;16:140-9. [PMID: 23509949 DOI: 10.1111/hpb.12087] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
142 Vernuccio F, Ronot M, Dioguardi Burgio M, Lebigot J, Allaham W, Aubé C, Brancatelli G, Vilgrain V. Uncommon evolutions and complications of common benign liver lesions. Abdom Radiol (NY) 2018;43:2075-96. [PMID: 29260281 DOI: 10.1007/s00261-017-1427-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
143 Belghiti J, Dokmak S, Vilgrain V, Paradis V. Benign liver lesions. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. Elsevier; 2012. pp. 1250-1267.e4. [DOI: 10.1016/b978-1-4377-1454-8.00079-5] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
144 Denecke T, Steffen IG, Agarwal S, Seehofer D, Kröncke T, Hänninen EL, Kramme IB, Neuhaus P, Saini S, Hamm B. Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI. Eur Radiol. 2012;22:1769-1775. [PMID: 22437921 DOI: 10.1007/s00330-012-2422-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
145 Choe MJ, Hinkel T, Berggruen SM. Imaging of Benign Hepatic lesions. Semin Ultrasound CT MR 2021;42:347-65. [PMID: 34130848 DOI: 10.1053/j.sult.2021.04.002] [Reference Citation Analysis]
146 Costa AF, Kajal D, Pereira A, Atri M. Should fat in the radiofrequency ablation zone of hepatocellular adenomas raise suspicion for residual tumour? Eur Radiol 2017;27:1704-12. [PMID: 27436025 DOI: 10.1007/s00330-016-4496-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
147 Bieze M, Phoa SS, Verheij J, van Lienden KP, van Gulik TM. Risk factors for bleeding in hepatocellular adenoma. Br J Surg. 2014;101:847-855. [PMID: 24760723 DOI: 10.1002/bjs.9493] [Cited by in Crossref: 66] [Cited by in F6Publishing: 46] [Article Influence: 9.4] [Reference Citation Analysis]
148 Bioulac-Sage P, Taouji S, Le Bail B, Possenti L, Balabaud C. Value and limits of routine histology alone or combined with glutamine synthetase immunostaining in the diagnosis of hepatocellular adenoma subtypes on surgical specimens. Int J Hepatol. 2013;2013:417323. [PMID: 23509631 DOI: 10.1155/2013/417323] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
149 Bieze M, Bennink RJ, El-massoudi Y, Phoa SS, Verheij J, Beuers U, van Gulik TM. The use of 18F-fluoromethylcholine PET/CT in differentiating focal nodular hyperplasia from hepatocellular adenoma: a prospective study of diagnostic accuracy. Nuclear Medicine Communications 2013;34:146-54. [DOI: 10.1097/mnm.0b013e32835afe62] [Cited by in Crossref: 11] [Article Influence: 1.4] [Reference Citation Analysis]
150 Ferrell LD, Kakar S, Terracciano LM, Wee A. Tumours and Tumour-like Lesions of the Liver. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 780-879. [DOI: 10.1016/b978-0-7020-6697-9.00013-3] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
151 Chan AW, Tong JH, Pan Y, Chan SL, Wong GL, Wong VW, Lai PB, To KF. Lymphoepithelioma-like hepatocellular carcinoma: an uncommon variant of hepatocellular carcinoma with favorable outcome. Am J Surg Pathol. 2015;39:304-312. [PMID: 25675010 DOI: 10.1097/pas.0000000000000376] [Cited by in Crossref: 37] [Cited by in F6Publishing: 11] [Article Influence: 6.2] [Reference Citation Analysis]
152 Nahm CB, Parker N, Gundara JS, Gill AJ, Bhimani N, Samra JS, Hugh TJ. Management of patients with hepatocellular adenoma: a single-institution experience. ANZ J Surg 2020;90:786-90. [PMID: 31943651 DOI: 10.1111/ans.15648] [Reference Citation Analysis]
153 Solbach P, Potthoff A, Raatschen HJ, Soudah B, Lehmann U, Schneider A, Gebel MJ, Manns MP, Vogel A. Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report. BMC Gastroenterol 2015;15:60. [PMID: 25986067 DOI: 10.1186/s12876-015-0288-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
154 Gjorgjieva M, Calderaro J, Monteillet L, Silva M, Raffin M, Brevet M, Romestaing C, Roussel D, Zucman-Rossi J, Mithieux G, Rajas F. Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia. J Hepatol 2018;69:1074-87. [PMID: 30193922 DOI: 10.1016/j.jhep.2018.07.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
155 Agrawal S, Agarwal S, Arnason T, Saini S, Belghiti J. Management of Hepatocellular Adenoma: Recent Advances. Clin Gastroenterol Hepatol. 2015;13:1221-1230. [PMID: 24909909 DOI: 10.1016/j.cgh.2014.05.023] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 7.9] [Reference Citation Analysis]
156 Goltz D, Fischer HP. [Hepatocellular tumours in noncirrhotic liver tissue]. Pathologe 2015;36:597-606; quiz 607-8. [PMID: 26496997 DOI: 10.1007/s00292-015-0113-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
157 Niedfeldt MW. Anabolic Steroid Effect on the Liver. Curr Sports Med Rep 2018;17:97-102. [DOI: 10.1249/jsr.0000000000000467] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 5.7] [Reference Citation Analysis]
158 Elfrink AKE, Haring MPD, de Meijer VE, Ijzermans JNM, Swijnenburg RJ, Braat AE, Erdmann JI, Terkivatan T, Te Riele WW, van den Boezem PB, Coolsen MME, Leclercq WKG, Lips DJ, de Wilde RF, Kok NFM, Grünhagen DJ, Klaase JM; Dutch Hepato Biliary Audit Group. Surgical outcomes of laparoscopic and open resection of benign liver tumours in the Netherlands: a nationwide analysis. HPB (Oxford) 2021;23:1230-43. [PMID: 33478819 DOI: 10.1016/j.hpb.2020.12.003] [Reference Citation Analysis]
159 Liu W, Delwaide J, Bletard N, Delvenne P, Meunier P, Hustinx R, Detry O. 18-Fluoro-deoxyglucose uptake in inflammatory hepatic adenoma: A case report. World J Hepatol 2017; 9(11): 562-566 [PMID: 28469812 DOI: 10.4254/wjh.v9.i11.562] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
160 Walia S, Aron M, Hu E, Chopra S. Utility of rapid on-site evaluation for needle core biopsies and fine-needle aspiration cytology done for diagnosis of mass lesions of the liver. J Am Soc Cytopathol 2019;8:69-77. [PMID: 31287422 DOI: 10.1016/j.jasc.2018.08.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
161 Grieser C, Steffen IG, Seehofer D, Kramme I, Uktolseya R, Scheurig-muenkler C, Hamm B, Denecke T. Histopathologically confirmed focal nodular hyperplasia of the liver: Gadoxetic acid-enhanced MRI characteristics. Magnetic Resonance Imaging 2013;31:755-60. [DOI: 10.1016/j.mri.2012.11.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
162 Ramia JM, Bernardo C, Valdivieso A, Dopazo C, Jover JM, Albiol MT, Pardo F, Fernandez Aguilar JL, Gutierrez Calvo A, Serrablo A, Diez Valladares L, Pereira F, Sabater L, Muffak K, Figueras J. Estudio multicéntrico sobre adenomas hepáticos. Cirugía Española 2014;92:120-5. [DOI: 10.1016/j.ciresp.2012.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
163 Mittal S, Gopal P, Khatri G, Singal AG. Evaluation and Management of Hepatocellular Adenomas. Clin Liver Dis (Hoboken) 2021;17:57-60. [PMID: 33680436 DOI: 10.1002/cld.949] [Reference Citation Analysis]
164 Myers L, Ahn J. Focal Nodular Hyperplasia and Hepatic Adenoma: Evaluation and Management. Clin Liver Dis 2020;24:389-403. [PMID: 32620279 DOI: 10.1016/j.cld.2020.04.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
165 Laurent A, Dokmak S, Nault JC, Pruvot FR, Fabre JM, Letoublon C, Bachellier P, Capussotti L, Farges O, Mabrut JY, Le Treut YP, Ayav A, Suc B, Soubrane O, Mentha G, Popescu I, Montorsi M, Demartines N, Belghiti J, Torzilli G, Cherqui D, Hardwigsen J; AFC-HCA-2013 Study Group. European experience of 573 liver resections for hepatocellular adenoma: a cross-sectional study by the AFC-HCA-2013 study group. HPB (Oxford) 2016;18:748-55. [PMID: 27593592 DOI: 10.1016/j.hpb.2016.06.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
166 Cotta-Pereira RL, Valente LF, De Paula DG, Eiras-Araújo AL, Iglesias AC. Rupture of a hepatic adenoma in a young woman after an abdominal trauma: A case report. World J Gastroenterol 2013; 19(27): 4422-4426 [PMID: 23885157 DOI: 10.3748/wjg.v19.i27.4422] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
167 Singh HK, Patkar S, Polnaya AM, Ramadwar M, Goel M. Giant Hepatic Adenoma in a 12-Year-Old Girl. J Gastrointest Cancer 2019;50:156-9. [PMID: 28865036 DOI: 10.1007/s12029-017-9999-5] [Reference Citation Analysis]
168 Fang C, Anupindi SA, Back SJ, Franke D, Green TG, Harkanyi Z, Jüngert J, Kwon JK, Paltiel HJ, Squires JH, Zefov VN, McCarville MB. Contrast-enhanced ultrasound of benign and malignant liver lesions in children. Pediatr Radiol 2021. [PMID: 33978801 DOI: 10.1007/s00247-021-04976-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
169 Mounajjed T. Hepatocellular Adenoma and Focal Nodular Hyperplasia. Clin Liver Dis (Hoboken) 2021;17:244-8. [PMID: 33968383 DOI: 10.1002/cld.1069] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
170 Klompenhouwer AJ, de Man RA, Dioguardi Burgio M, Vilgrain V, Zucman-Rossi J, Ijzermans JNM. New insights in the management of Hepatocellular Adenoma. Liver Int 2020;40:1529-37. [PMID: 32464711 DOI: 10.1111/liv.14547] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
171 Shyu S, Ali SZ. Significance of hepatocyte atypia in liver fine needle aspiration. Diagn Cytopathol 2021. [PMID: 34459153 DOI: 10.1002/dc.24851] [Reference Citation Analysis]
172 Sempoux C, Balabaud C, Bioulac-Sage P. Malignant transformation of hepatocellular adenoma. Hepat Oncol. 2014;1:421-431. [PMID: 30190977 DOI: 10.2217/hep.14.14] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
173 Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, Kreipe H, Lehmann U. Loss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma. PLoS One. 2012;7:e49462. [PMID: 23145177 DOI: 10.1371/journal.pone.0049462] [Cited by in Crossref: 90] [Cited by in F6Publishing: 93] [Article Influence: 10.0] [Reference Citation Analysis]
174 Vily-Petit J, Soty-Roca M, Silva M, Raffin M, Gautier-Stein A, Rajas F, Mithieux G. Intestinal gluconeogenesis prevents obesity-linked liver steatosis and non-alcoholic fatty liver disease. Gut 2020;69:2193-202. [PMID: 32205419 DOI: 10.1136/gutjnl-2019-319745] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
175 Carnevale A, Pellegrino F, Cossu A, Ierardi AM, Parenti GC, Carrafiello G, Giganti M. Current concepts in ablative procedures for primary benign liver lesions: a step forward to minimize the invasiveness of treatment when deemed necessary. Med Oncol 2020;37:31. [PMID: 32193648 DOI: 10.1007/s12032-020-01355-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
176 Auer TA, Walter-Rittel T, Geisel D, Schöning W, Schmelzle M, Müller T, Sinn B, Denecke T, Hamm B, Fehrenbach U. HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI. BMC Med Imaging 2021;21:28. [PMID: 33588783 DOI: 10.1186/s12880-021-00552-0] [Reference Citation Analysis]
177 Liu Y, Li H, Ye N, Luo CJ, Hu YY, Wu H, Gong JP. Non-Cirrhotic Liver is Associated with Poor Prognosis of Hepatocellular Carcinoma: A Literature Review. Med Sci Monit 2019;25:6615-23. [PMID: 31479436 DOI: 10.12659/MSM.915722] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
178 Hepkema JT, Poelmann FB, Gouw ASH, de Haas RJ, Duiker EW, Blokzijl H, Klaase JM. Malignant Transformation of an HNF1a-Inactivated Hepatocellular Adenoma to Hepatocellular Carcinoma. Case Rep Gastroenterol 2020;14:577-85. [PMID: 33250700 DOI: 10.1159/000510215] [Reference Citation Analysis]
179 Klompenhouwer AJ, Ijzermans JNM. Malignant potential of hepatocellular adenoma. Liver Int 2017;37:966-7. [DOI: 10.1111/liv.13449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
180 Klompenhouwer AJ, Sprengers D, Willemssen FEJA, Gaspersz MP, Ijzermans JNM, De Man RA. Evidence of good prognosis of hepatocellular adenoma in post-menopausal women. Journal of Hepatology 2016;65:1163-70. [DOI: 10.1016/j.jhep.2016.07.047] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
181 Kurzbard-Roach N, Jha P, Poder L, Menias C. Abdominal and pelvic imaging findings associated with sex hormone abnormalities. Abdom Radiol (NY) 2019;44:1103-19. [PMID: 30483844 DOI: 10.1007/s00261-018-1844-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
182 Vijay A, Elaffandi A, Khalaf H. Hepatocellular adenoma: An update. World J Hepatol 2015; 7(25): 2603-2609 [PMID: 26557953 DOI: 10.4254/wjh.v7.i25.2603] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
183 Ehrl D, Rothaug K, Herzog P, Hofer B, Rau HG. "Incidentaloma" of the liver: management of a diagnostic and therapeutic dilemma. HPB Surg 2012;2012:891787. [PMID: 22927707 DOI: 10.1155/2012/891787] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]